Tag: Prescription Drugs
Dementia Incidence Increased With Termination of Metformin
Association largely independent of changes in hemoglobin A1c and insulin usage
TCT: Ticagrelor Monotherapy Within One Month of DAPT Noninferior to Continued DAPT
Major bleeding occurred in fewer patients in group receiving ticagrelor monotherapy after less than one month of DAPT versus 12-month DAPT group
Industry Payments to Doctors Tied to Nonrecommended, Low-Value Drug Use
Payment from industry associated with increased use of denosumab, GCSF, and nab-paclitaxel, lower use of branded drugs
In Utero Corticosteroid Exposure Not Detrimental to Offspring Neurodevelopment
However, for β2-adrenergic agonists, association seen between mid-to-late pregnancy exposure and delayed personal-social skills
Patisiran Can Preserve Functional Capacity in ATTR Amyloidosis
Decline in six-minute walk distance lower in patisiran versus placebo group at month 12
Nemolizumab Improves Symptoms in Prurigo Nodularis
Treatment efficacy seen in primary end points of itch response and Investigator's Global Assessment response
Tapinarof Cream Safe, Effective for Plaque Psoriasis in Intertriginous Areas
12-week benefits include high rates of skin clearance, meaningful itch relief
ESMO: Pembrolizumab + Chemo, Trastuzumab Beneficial in Gastroesophageal Cancer
Improvement seen in progression-free survival with add-on pembrolizumab in gastroesophageal junction adenocarcinoma
Ketamine No Better Than Placebo for Depression
Intravenous ketamine delivered during surgical anesthesia has no greater effect than placebo in reducing severity of depression
Sotorasib + Panitumumab Beneficial for Chemorefractory Metastatic CRC
Reduced hazard ratio seen for disease progression or death with sotorasib-panitumumab versus standard care
